Melatonin, and Opioid Peptide Interactions in Tardive Dyskinesia

References

• Anton‐Tay F., Diaz J. L., Fernandez‐Guardiola A. On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Sciences 1971; 10: 841–850
   Web of Science ®Google Scholar
• Bedard P. J., Langelier P., Dankova J., Villeneuve A., Di Paolo T., Barden N., Labrie F., Boissier J. R., Euvrard C. Estrogens, progesterone, and the extraphymidal system. Advances in neurology, L. J. Poirier, T. L. Sorkes, P. J. Bedard. Raven Press, New York 1979; v: 411–422
   Google Scholar
• Bedard P., Langelier P., Villeneuve A. Estrogens and the extrapyramidal system. Lancet 1977; 1: 1367–1368
   Google Scholar
• Burke R. E. Tardive dyskinesia: current clinical issues. Neurology 1984; 34: 1348–1353
   PubMed Web of Science ®Google Scholar
• Cotzias G. C., Tang L. C., Miller S. T., Ginos J. Z. Melatonin and abnormal movements induced L‐dopa in mice. Science 1971; 173: 450–552
   PubMed Web of Science ®Google Scholar
• Erlich S. S., Apuzzo M. L. J. The pineal gland: anatomy, physiology and clinical significance. Journal of Neurosurgery 1985; 63: 321–341
   PubMed Web of Science ®Google Scholar
• Ferin M. Endogenous opioid peptides and the menstrual cycle. Trends in Neurosciences June, 1984; 194–196
   Google Scholar
• Ferrier I. N., Arendt J., Johnstone E. C., Crow T. J. Reduced nocturnal melatonin secretion in chronic schizopherenia: relationship to body weight. Clinical Endocrinology 1982; 17: 181–187
   PubMed Web of Science ®Google Scholar
• Glazer W. M., Naftolin F., Morgenstern H., Barnea E. R., Maclusky N. J., Brenner L. M. Estrogen replacement and tradive dyskinesia. Psychoneuroendocrinology 1985; 10: 345–350
   PubMedGoogle Scholar
• Houssay A. B., Barcelo A. C. Effects of estrogens and rogesterone upon thebiosynthesis of melatonin by the pineal gland. Experientia 1972; 24: 478–479
   Google Scholar
• Kavaliers M., Hirst M., Teskey G. C. Ageing, opioid analgesia and the pineal gland. Life Sciences 1983; 32: 2279–2287
   PubMed Web of Science ®Google Scholar
• Jus A., Pineau R., Lachance R. Epidemiology of tardive dyskinesia, part I. Diseases of the Nervous System 1976; 32: 210–214
   Google Scholar
• Kennedy P. F., Hershon H. I., McGuire R. J. Extrapyramidal disorders after prolonged phenothiazine therapy. British Journal of Psychiatry 1971; 118: 509–518
   PubMed Web of Science ®Google Scholar
• Roller W. C., Barr A., Biary N. Estrogen treatment of dyskinetic disorders. Neurology 1984; 32: 547–549
   Google Scholar
• Kopp N., Claustrat B., Tappaz M. Evidence for the presence of melatonin in the human brain. Neuroscience Letters 1980; 19: 237–242
   PubMed Web of Science ®Google Scholar
• Kumar M. S. A., Besch E. L., Millard W. J., Sharp D. C., Leadem C. A. Effect of short photoperiod on hypothalmic methionine‐enkephalin and LHRH content and serum beta‐endorphinlike immunoreactivity (beta‐end Li) levels in golden hamsters. Journal of Pineal Research 1984; 1: 197–205
   PubMed Web of Science ®Google Scholar
• Lakin M. L., Miller C. H., Statt M. L., Winters W. D. Involvement of the pineal gland and melatonin in murine analgesia. Life Sciences 1981; 29: 2543–2551
   PubMed Web of Science ®Google Scholar
• Lissoni P., Esposti D., Esposti G., Mauri R., Resentini M., Morabito F., Fumagalli P., Santagostino A., Delitala G., Fraschini F. A clinical study on the relationship between the pineal gland and the opioid system. Journal of Neural Transmission 1986; 65: 63–73
   PubMed Web of Science ®Google Scholar
• Lowenstein P. R., Pereyra E. N., Solveyra C. G., Cardinali D. P. Effect of naloxone on the nocturnal rise of rat pineal melatonin content. European Journal of Pharmacology 1984; 98: 261–264
   PubMed Web of Science ®Google Scholar
• Mendelwicz J., Likowski P., Branchey L., Weinberg U., Weitzman E. D., Branchey M. Abnormal 24 hour pattern of melatonin secretion in depression. Lancet 1979; 2: 1361
   Google Scholar
• Reid R. L., Quigley M. E., Yen S. S. C. The disapearance of opioiderigic regulation of gonadotropin secretion in postmenopausal women. Jornal of Clinical Endocrinology & Metabolism 1983; 57: 1107–1110
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Melatonin mediates the antidyskinetic effects of naloxone in tardive dyskinesia. Journal of Clinical Psychopharamacology 1989; 9: 147–148
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Melatonin potentiates the effects of naloxone on reserpine‐induced catalepsy in the rat. International Journal of Neuroscience
   Google Scholar
• Sandyk R., Fisher H. Enhancement of neuroleptic‐induced movement disorder in the rat by pinealectomy. International Journal of Neuroscience
   Google Scholar
• Schipper H. M. Neurology of sex steroids and oral contraceptives. Neurologic Clinics 1986; 4: 721–751
   PubMed Web of Science ®Google Scholar
• Steardo L., Monteleone P., Tamminga C. A., Canonico P. L., Denman D., Scapagnini U., Chase T. N. Differential responses in prolactin levels induced by naloxone in humans. Psychoneuroendocrinology 1985; 10: 203–209
   PubMedGoogle Scholar
• Trentini G. P., De Gaetani C. F., Criscuolo M., Migaldi M., Ferrari G. Pineal calcification in different physiopathological conditions in humans. Fundamentals and Clinics in Pineal Research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven press, New York 1987; 291–304
   Google Scholar
• Van Loon G. R., Shum A., George S. R., Shin S. H. Prolactin increases the activity of tuberoinfundibular and nigrostriatal dopamine neurons: prolactin antiserum inhibits the haloperidolinduced increases in dopamine synthesis rates in median eminence and striatum of rats. Brain Research Bulletin 1983; 10: 539–545
   PubMed Web of Science ®Google Scholar
• Villeneuve A., Cazejust T., Cote M. Estorogen in tardive dyskinesia. Canadian Psychiatric Association Journal 1980; 23: 68–70
   Google Scholar
• Waldhauser F., Steger H. Changes in melatonin secretion with age and pubescence. Journal of Neural Transmission 1983; 272: 378–381, (suppl)
   Google Scholar
• Wardlaw S. L., Wehrenberg W. B., Ferin M., Antunes J. L., Frantz A. G. Effect of sex steroids on beta‐endorphin in hypophyseal portal blood. Journal of Clinical Endocrinology & Metabolism 1982; 55: 877–881
   PubMed Web of Science ®Google Scholar
• Wehrenberg W. B., Wardlaw S. L., Frantz A. G., Ferin M. Beta‐endorphin in hypophyseal portal blood variations throughtout the menstrual cycle. Endocrinology 1982; 111: 879–881
   PubMed Web of Science ®Google Scholar